USPTO serial 79290974
OR2PACK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 1, 2021
- Examiner
- MORRIS, KRISTINA KLOIBER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with OR2PACK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-38000 Grenoble, FR
F-38000 Grenoble, FR
F-38000 Grenoble, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet G Ricciuti
Janet G Ricciuti JANET GILBERT RICCIUTI1830 S STREET NWWASHINGTON, DC 20009UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Packaging solution for pharmaceutical use, namely, drug delivery agents embedded in matrixes that provide controlled release of the active ingredients for a wide variety of pharmaceuticals, the above-mentioned product not in connection with the region of the ear | ACTIVE | — |
| 010 | Surgical apparatus and instruments; protections for medical instruments, namely, carrying cases specially adapted for holding or carrying medical implants; medical device packaging solution, namely, carrying cases specially adapted for medical implants; the above-mentioned products not in connection with the region of the ear | ACTIVE | — |
| 042 | Product design analysis and evaluation, product development analysis and evaluation, packaging solution design, prosthesis design, pharmaceutical product development, industrial product development, development of packaging solutions for pharmaceutical and surgical use, testing of pharmaceutical and surgical products, research and development of new products, pharmaceutical research and development, research and development for the pharmaceutical industry, engineering service, testing of new pharmaceutical and surgical products, the above-mentioned services not related to the ear area | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by A. RAYMOND et Cie
- Other trademarks owned by A. RAYMOND et Cie
- Other trademarks owned by A. RAYMOND et Cie
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named OR2PACK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 1, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 11, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 21, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 21, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 1, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 1, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 24, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 24, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 9, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 9, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 9, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 9, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 9, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2021 | ALIE | ASSIGNED TO LIE | — |
| Oct 19, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 1, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 1, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 13, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 12, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 7, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |